Naglazyme and diarrhoea Patient Reports February 11, 2012

Naglazyme Side Effects Report #6017353-3
Naglazyme side effect was reported by a Physician from BRAZIL on Dec 04, 2008. Female patient, 26 years of age, weighting 59.52 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: cholelithiasis, diarrhoea, infusion related reaction, oedema, vomiting. Naglazyme dosage: 25 MG;QW; IVDRP. During the same period patient was treated with FLEBOCORTID. Patient recovered.

Naglazyme Side Effects Report #6106779-5
Naglazyme side effect was reported by a Physician from BRAZIL on Feb 17, 2009. Female patient, 26 years of age, weighting 59.52 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: cholelithiasis, diarrhoea, oedema. Naglazyme dosage: 25 MG QW IVDRP. During the same period patient was treated with FLEBOCORTID. Patient recovered.

Naglazyme Side Effects Report #5673975-0
Naglazyme side effect was reported by a Consumer or non-health professional from IRELAND on Feb 29, 2008. Female patient, child 11 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, aortic valve incompetence, back pain , blood pressure decreased, cardiac arrest , diarrhoea, headache , hepatomegaly. Naglazyme dosage: 20 MG; QW; IV. During the same period patient was treated with MEROPENEM, VANCOMYCIN, ERYTHROMYCIN, CIPROFLOXACIN, VORICONAZOLE, MILRINONE LACTATE, FUROSEMIDE, MORPHINE. Patient was hospitalized. Patient died on 01/25/2008.

Naglazyme Side Effects Report #5923624-9
Naglazyme side effect was reported by a Consumer or non-health professional from AUSTRALIA on Oct 01, 2008. Female patient, weighting 22.05 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, choking , diarrhoea, infusion related reaction, lower respiratory tract infection, upper respiratory tract infection, viral infection , vomiting. Naglazyme dosage: 10.5 MG;QW; IVDRP. During the same period patient was treated with CETIRIZINE, IBUPROFEN, HYDROCORTISONE, PREDNISOLONE. Patient was hospitalized. Patient recovered.